- Home
- MLR vs ABCL Comparison
MLR vs ABCL Comparison
Compare MLR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLR
- ABCL
- Stock Information
- Founded
- MLR 1990
- ABCL 2012
- Country
- MLR United States
- ABCL Canada
- Employees
- MLR N/A
- ABCL N/A
- Industry
- MLR Construction/Ag Equipment/Trucks
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- MLR Consumer Discretionary
- ABCL Health Care
- Exchange
- MLR Nasdaq
- ABCL Nasdaq
- Market Cap
- MLR 769.3M
- ABCL 895.0M
- IPO Year
- MLR 1994
- ABCL 2020
- Fundamental
- Price
- MLR $67.78
- ABCL $2.69
- Analyst Decision
- MLR Strong Buy
- ABCL Buy
- Analyst Count
- MLR 1
- ABCL 3
- Target Price
- MLR $82.00
- ABCL $8.50
- AVG Volume (30 Days)
- MLR 85.1K
- ABCL 2.4M
- Earning Date
- MLR 11-12-2024
- ABCL 11-04-2024
- Dividend Yield
- MLR 1.08%
- ABCL N/A
- EPS Growth
- MLR 35.81
- ABCL N/A
- EPS
- MLR 6.02
- ABCL N/A
- Revenue
- MLR $1,331,839,000.00
- ABCL $32,962,000.00
- Revenue This Year
- MLR $16.10
- ABCL N/A
- Revenue Next Year
- MLR $6.72
- ABCL $36.56
- P/E Ratio
- MLR $11.26
- ABCL N/A
- Revenue Growth
- MLR 22.98
- ABCL N/A
- 52 Week Low
- MLR $38.33
- ABCL $2.34
- 52 Week High
- MLR $78.25
- ABCL $6.06
- Technical
- Relative Strength Index (RSI)
- MLR 38.82
- ABCL 42.74
- Support Level
- MLR $71.24
- ABCL $2.76
- Resistance Level
- MLR $72.80
- ABCL $3.05
- Average True Range (ATR)
- MLR 1.99
- ABCL 0.17
- MACD
- MLR -0.76
- ABCL -0.03
- Stochastic Oscillator
- MLR 4.72
- ABCL 6.98
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.